Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • Page [1] ·  Next »
NCT ID: NCT06416891 Not yet recruiting - Postoperative Pain Clinical Trials

Effect of Adding Dexamethasone to Bupivacaine 0.25% in SCPB on Surgical Field Visibility During Tympanomastoid Surgery

Start date: May 15, 2024
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate the efficacy of adding dexamethasone to bupivacaine 0.25% in ultrasound-guided SCPB on surgical field visibility during tympanomastoid surgery.

NCT ID: NCT06414759 Not yet recruiting - Edema Clinical Trials

Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload

Start date: May 22, 2024
Phase: Phase 4
Study type: Interventional

This study aims to compare two medications, acetazolamide and metolazone, along with loop diuretics, to see which one works better and is safer for patients with ADHF who have volume overload. By comparing these medications, we hope to learn which one can help these patients the most. This will help doctors choose the best treatment for patients with ADHF and volume overload.

NCT ID: NCT06411444 Not yet recruiting - Clinical trials for Cleft Lip and Palate

Effect of Different Nasal Stent Designs With Nasoalveolar Molding Appliance

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

This study is designed to compare 2 different designs of nasal stents in conjunction with nasoalveolar molding appliance regarding the changes in nose and lip esthetics in infants with cleft lip and palate.

NCT ID: NCT06405243 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Start date: June 30, 2024
Phase: Phase 3
Study type: Interventional

The aim of the study is to compare and assess the efficacy of combined letrozole with myoinositol, chromium, or L-arginine in infertile women with PCOS. This study will help in the investigation of alternative therapeutic modalities for fertility improvement in polycystic ovarian syndrome

NCT ID: NCT06405204 Not yet recruiting - IVF Clinical Trials

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Start date: June 30, 2024
Phase: Phase 3
Study type: Interventional

To evaluate the role of Myo-inositol, melatonin and co-enzyme Q10 on ovarian reserve parameters and ICSI outcome in poor ovarian responder

NCT ID: NCT06405178 Not yet recruiting - Polycystic Ovary Clinical Trials

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Start date: September 30, 2024
Phase: Phase 3
Study type: Interventional

The aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.

NCT ID: NCT06401798 Not yet recruiting - Clinical trials for Periodontitis Chronic Localized Slight

Locally Delivered Whey Protein Nanoparticles Gel in Stage II Grade B Periodontitis

Start date: May 5, 2024
Phase: N/A
Study type: Interventional

Aim of the current study is to evaluate radiographic and clinical alterations following topical application of CWP gel and CWP nanoparticles gel in stage II grade B periodontitis patients.

NCT ID: NCT06399783 Not yet recruiting - Alopecia Areata Clinical Trials

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Start date: October 1, 2024
Phase: Phase 4
Study type: Interventional

Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss of the scalp or any hair-bearing surface. Alopecia areata affects approximately 2% of the general population. AA has a significant influence on patients' quality of life and may induce psychological disorders. In AA, CD4+ and CD8+ T-cells violate the immune privilege of the anagen hair follicle, leading to loss of the growing hair shaft. A genome-wide association study demonstrated a genetic predisposition to AA . Additionally, environmental insults, such as viral infections, trauma, or psychosocial stress, have also been suspected to possibly contribute to the development of the disease . The clinical manifestations of AA vary from small well-defined patches of hair loss to the diffuse involvement of the scalp or the entire body. The majority of AA patients experience unpredictable relapsing and remitting episodes. In a number of patients, it can be persistent, especially when the hair loss is extensive.

NCT ID: NCT06397521 Not yet recruiting - Crown Lengthening Clinical Trials

Gingival Margin Stability Following Esthetic Crown Lengthening Utilizing a Double Periodontal Surgical Guide

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

In patients with excessive gingival display, esthetic crown lengthening procedure by means of scalpel, diode laser or electro-surgery could result in the same gingival marginal stability at 3 and 6 months follow up.

NCT ID: NCT06386926 Not yet recruiting - Clinical trials for Supraspinatus Tendinitis

Radial Shockwave Versus Ultrasound Phonophoresis

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Comparative study to compare the effect of radial shockwave versus ultrasound phonophoresis in management of chronic supraspinatus tendinitis consists of 3 groups exp1(shockwave treatment + conventional physical therapy) , exp2( ultrasound phonophoresis+ conventional physical therapy) and control group ( conventional physical therapy)